Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001104659-25-006782

Director acquired 3,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Androski Lindsay · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-24 Exercise or conversion : show line 1 in the form +3,750 15,750 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-24 Exercise or conversion : show line 2 in the form Restricted Stock Units −3,750 3,750 D
Loading xslF345X05/tm254730-2_4seq1.xml…